恆宇集團(02448.HK)擬折讓8.00%配售6000萬股 淨籌約1.36億港元
格隆匯 3 月 17日丨 恆宇集團(02448.HK)公吿,於2021年3月17日,公司與配售代理訂立配售協議,據此,公司已有條件同意透過配售代理盡最大努力配售6000萬股新股份予不少於六名獨立承配人,配售價為每股配售股份2.3港元。配售股份相當於經配發配售股份擴大後公司已發行股約7.32%。配售價2.3港元較2021年3月17日收市價每股2.5港元折讓8.00%。
集團主要業務為(i)裝修工程;(ii)樓宇建造工程;及(iii)提供金融服務,包括證券買賣、包銷、提供投資建議及資產管理。董事認為配售事項乃集團籌集額外資以推動其未來擴張及業務發展良機。
公司擬將配售事項的所得款項淨額約1.36億港元用作集團的一般營運資金及未來擴張。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.